Oracle: the cheapest way to own AI compute

CORBANU · TRADE NOTE · 27 SEPTEMBER 2026

The trade

LONG ORCLon, the Ondo tokenized Oracle share, held spot on Felix, against a reference quote of 139.16 USD observed at 2026-09-26T23:10:53Z (a reference price, not an executed fill), for a horizon to 2028-09-30. Oracle trades at 8.8x the Street's fiscal 2029 earnings. After September's credit scare, the market is pricing the capex and debt and giving less weight to the contracted backlog those outlays are building. The catalysts are OpenAI's next funding round, the December 2026 and March 2027 quarterly results and the New Mexico permit decisions. The thesis fails if OpenAI cannot fund its commitment, if backlog conversion slips, or if Oracle has to sell stock at these prices.

The probability-weighted target is $231.75 by 2028-09-30, a price return of +66.5%. That figure is the average of three scenario targets, weighted by probability: bear $72.73, base $240.83 and bull $350.65. The valuation chart shows all three.

LONG ORCLon · Felix (Ondo spot) · reference quote 139.16 USD · as of 2026-09-26T23:10:53Z · horizon 2028-09-30 · unlevered spot, no funding.

Sizing: 2.52% of capital, unlevered spot, part of our vol-weighted book: 5.0% short Apple (Apple short), 1.33% long SK hynix (SK hynix long) and 2.52% long Oracle (Oracle long). Each position carries the same risk: 5.0% of capital × Apple's 28.5% 63-day volatility = 1.43% of capital in annualized volatility, and each size is 1.43% divided by that instrument's own 63-day volatility (SK hynix 107.2%, Oracle 56.5%; Hyperliquid daily closes, 30 June–25 September 2026). There is no market-beta hedge: Apple's 63-day correlation to the Nasdaq-100 is currently negative, so a beta-based hedge ratio is unstable. Gross exposure across the three positions is 8.85% of capital, with book volatility of about 3.4% of capital. Sizing data

The exposure

Oracle has three businesses.

OCI revenue was $7.4B in the quarter to 31 August 2026, up 121% (Oracle Q1 FY27 results). Of that, the CPU-and-GPU line contributed $6.5B, up 151% (Q1 FY27 earnings slides).

Under take-or-pay terms, customers pay for AI capacity for five to six years whether they use it or not. Oracle pays for the chips up front and leases the buildings. It had $288B of leases that had not yet started at quarter end, with terms of 15 to 19 years, beginning between now and fiscal 2029 (Q1 FY27 10-Q). The cash goes out before any revenue comes in, because revenue starts only when a site goes live. That is why free cash flow is deeply negative during the build.

Remaining performance obligations (RPO) are contracted revenue that Oracle has yet to recognise. RPO stood at $664B at quarter end, about 1.6 times Oracle's market value of roughly $421B at the reference price. The 10-Q gives the schedule: about 13% is expected to be recognised within twelve months, 37% in months 13 to 36, 34% in months 37 to 60 and the remainder after that. Shareholders gain if this backlog turns into earnings faster than depreciation, interest and new share issuance eat into it.

Oracle's $664 billion backlog split by expected recognition: 13% within a year, 37% in years two and three, 34% in years four and five, 16% later

Most of Oracle's contracted backlog is scheduled to turn into revenue between one and five years out. Source: Oracle Q1 FY27 10-Q; dollar values are approximate.

The trade holds Oracle through ORCLon, a token backed one-for-one by Oracle shares that reinvests the dividend, so it tracks the listed share's total return without leverage or funding costs. Unlike the NYSE share, it carries no vote and depends on the issuer's custody; the appendix covers those differences.

Why now

In September, Oracle sent two signals in opposite directions, and the stock followed the more worrying one.

Dated readings of Oracle's five-year credit default swap spread rising from about 160 basis points in June to between 227 and 241 in late September

Oracle's five-year CDS in 2026, from published reports and Bloomberg. Markers show quoting basis; the points are observations, not a continuous series.

At today's price, each later year of earnings is priced at a lower multiple. Bloomberg consensus, dated 25 September, has EPS of $8.16 for the year to May 2027, $11.07 for fiscal 2028, $15.73 for fiscal 2029 and $20.46 for fiscal 2030. At the 139.16 reference quote, that is 17.1x this year, 12.6x next year, 8.8x fiscal 2029 and 6.8x fiscal 2030. The 50 analysts Bloomberg tracks have an average target of $240. On 9 September, at $162.52, Oracle traded at about 21x forward earnings, against 27x for Microsoft and 36x for Amazon (Yahoo Finance). Since then the stock has fallen about 15% while earnings guidance has gone up.

Against enterprise software and the other clouds, Oracle is the cheapest grower. Apart from the much smaller CoreWeave, it has the fastest consensus revenue growth in the table and the lowest multiple on next year's earnings. Its price-to-earnings-to-growth ratio (PEG) is about a third of the hyperscalers'.

Company Market cap Revenue growth, next FY EPS growth, year after P/E, next FY EV/EBITDA, next FY PEG
Oracle $416B 45% 42% 12.4x 7.5x 0.29
Microsoft $3,833B 19% 22% 21.9x 13.0x 1.02
Amazon $2,693B 15% 25% 20.1x 9.5x 0.79
Alphabet $4,189B 26% 23% 21.5x 13.9x 0.95
CoreWeave $49B 106% n/m n/m 7.0x n/m
SAP $259B 12% 19% 22.0x 14.4x 1.13
Salesforce $193B 10% 15% 14.6x 10.0x 0.95
IBM $212B 4% 8% 17.2x 12.2x 2.09
MongoDB $33B 18% 22% 52.6x 36.7x 2.41
ServiceNow $140B 19% 21% 27.0x 17.8x 1.27
Hyperscaler average (Microsoft, Amazon, Alphabet) 20% 23% 21.2x 12.2x 0.92
Software average (SAP, Salesforce, IBM, MongoDB, ServiceNow) 12% 17% 26.7x 18.2x 1.57
Peer median (all eight, excluding CoreWeave) 16% 21% 21.7x 13.5x 1.07

Bloomberg BEST consensus and closing prices, 25 September 2026. Each company's own fiscal years: Oracle's next fiscal year ends May 2028, Microsoft's June 2028, Salesforce's and MongoDB's January 2028, the rest December 2027. PEG is next-year P/E divided by the following year's EPS growth. EV/EBITDA is enterprise value over next-year consensus EBITDA, so it counts Oracle's debt. CoreWeave has no positive EPS until its third year.

Against the peer median, Oracle is growing revenue nearly three times as fast (45% against 16%) and EPS twice as fast (42% against 21%), yet it trades at 12.4x next year's earnings against 21.7x, a PEG of 0.29 against 1.07. The discount survives Oracle's debt: at 7.5x next year's EBITDA against a peer median of 13.5x, it is priced in line with the far smaller CoreWeave.

Four months ago, the stock stood at our base-case target. Oracle shares rose about 40% in May as OpenAI raised new money and said it was on track to meet its revenue targets (Motley Fool). The shares peaked at $248.15 in early June. To compare that peak with today, the table uses the 10 June and 10 September earnings calls alongside Bloomberg consensus:

June Now
Share price $248.15 (early-June peak) $137.10 (25 Sep close)
Consensus EPS FY28 / FY29 $10.78 / $15.62 $11.07 / $15.73
P/E on FY29 EPS 15.9x 8.7x
Consensus target price $245 $240
Remaining performance obligations $553B at the peak; $638B reported 10 June $664B
GPU utilisation 97.5% 97.9%
FY27 EPS guidance $8.05 (10 June) $8.10
Credit rating (S&P) BBB BBB-
Five-year CDS (Bloomberg) ~160bp ~241bp

Consensus, target and CDS figures are Bloomberg data supplied by the author; published CDS reports use a different quoting convention and are discussed above.

The operating numbers are flat or better. Consensus EPS is higher even after the at-the-market sale of 141M new shares, about 5% of the company (Q1 FY27 10-Q). The financing picture has worsened:

These are real costs. Even so, the price has fallen 45% while the earnings the market is pricing have not.

Customers fund a large share of the build, and the rest can be financed. Last quarter Oracle received $11.4B of customer prepayments, about 40% of the $28.5B it spent on capex (Q1 FY27 10-Q). For the full year, gross capex is guided at $90–95B, with net cash spending of about $70B after $20–25B of prepayments (CNBC). Oracle signed more than $30B of AI contracts in the quarter and said they have "no incremental impact" on its capital-raising plans (Oracle Q1 FY27 results). CFO Hilary Maxson says each project, once ramped, converts "something like 100%" of post-tax EBITDA into free cash flow, because the chips are bought once (Q1 FY27 earnings call transcript). She did not give a date for company-wide free cash flow to turn positive.

The rest of the gap can be counted. From September 2026 to the end of fiscal 2029, the cash Oracle needs and what it already has look like this (balance-sheet and cash-flow items from the Q1 FY27 10-Q):

Uses, 1 Sep 2026 to 31 May 2029 $B
Consensus free cash flow deficit (rest of FY27, FY28, FY29) 58.7
Dividends at last quarter's $1.57B a quarter 17.2
Debt due within twelve months 7.6
Total uses 83.5
Sources
Cash at 31 August, which already includes the $19.9B at-the-market sale 36.4
Rest of the fiscal 2027 plan: $40B of debt and equity less the $20B sale already done 20.0
Remaining need, before any minimum cash balance 27.1

The free-cash-flow line takes Bloomberg's fiscal 2027 consensus of −$34.5B less the −$5.4B already spent in the first quarter. The base case covers the remaining need: its share count rises from 3.02B to 3.12B, and 100M new shares at around $170 would raise about $17B, leaving roughly $10B of new debt. Debt maturing after the next twelve months would be refinanced on top of that. The fiscal 2027 plan is from the 10 June call (CNBC).

What the stock pays for each year of consensus earnings, and consensus free cash flow

At entry, price is divided by Bloomberg consensus EPS and by consensus free cash flow, using the fiscal year ending 31 May.

Free cash flow explains the gap. Consensus has it at −$34.5B this year and −$29.4B next year, reaching about zero in fiscal 2029 and +$24B in fiscal 2030. Until that turn, the market prices Oracle as a borrower under stress. The two-year horizon runs up to the change: once free cash flow stops being negative, the stock should be valued on its earnings.

The capex economics are attractive. At Oracle's October 2025 analyst meeting, co-CEO Clay Magouyrk set out a one-gigawatt example:

Oracle guided AI-infrastructure gross margins of 30–40% at the same meeting (CreditSights). The cash arithmetic below adds two assumptions of our own, a 21% tax rate and other costs of 2% of revenue:

Waterfall from 10 billion dollars of annual revenue per gigawatt to 6.83 billion dollars of annual free cash flow after facility, other costs and tax

One gigawatt of AI capacity on Oracle's illustrative terms, with our tax and cost assumptions. Values in $B per year.

Six years at $6.83B a year on $25.35B of up-front chip spending gives a 3.7-year payback and an unlevered return of about 16%. Revenue has to stay above about $8.6B per gigawatt-year to clear a 9.5% cost of capital; the undiscounted cash break-even is about $6.7B.

The lease term creates the main uncertainty. Building leases run 15 to 19 years, so each gigawatt needs a new tenant or a renewal when its first contract ends, and the renewal price decides whether the return holds. OpenAI's contract gives a better benchmark: $300B over five years for about 4.5GW works out to roughly $13.3B per gigawatt-year (Yahoo Finance).

Utilisation last quarter was 97.9%. GPUs coming off contract, most of them at least four years old, were renewed or resold at a 20% premium (Q1 FY27 earnings call transcript). The chips keep earning after their first contract: hardware that bears write off after one lease is going back out at a higher price.

Demand still exceeds supply.

Monthly npm downloads of OpenAI Codex and Anthropic Claude Code, February 2025 to August 2026

Monthly npm downloads of the two coding-agent command-line tools. Codex's May 2026 figure of 239M was an install-loop spike and is drawn off scale. Source: npm registry.

Customers can pay.

Is this a leveraged long on OpenAI? Partly, and the price already charges for it. OpenAI's $300B contract is roughly half of Oracle's backlog. At about $60B a year it is larger than OpenAI's current revenue, so fundraising covers the gap, and OpenAI's access to capital is the biggest single input to this trade. Three things make that exposure better than the credit market is pricing:

The bear case already assumes half of OpenAI's ramp never arrives and gives it 25%. The price does not credit the other side: a closed round at $1.2T or more would be the most direct fix for the risk S&P named when it cut Oracle to BBB-. The last time OpenAI raised money, in May, Oracle's shares rose about 40%.

Oracle is protecting its position as tenant, and the landlord says nothing has changed. Bloomberg first reported the force-majeure notice on Project Jupiter, a 2.45GW Stargate campus in Doña Ana County, New Mexico. The notice keeps open Oracle's right to delay rent if the campus misses its 2028 online date. Blue Owl and its STACK platform are the developer and landlord. A person familiar with the matter said the notice is not a default under the project financing. About $18B of project loans were quoted at 89–91 cents on the dollar afterwards, according to the Financial Times.

The dispute is about on-site power. The State Land Office has twice refused the gas pipeline's route across state trust land (Albuquerque Journal), pushing the pipeline target to 1 February 2027. Oracle says Jupiter "remains on our planned schedule," and Blue Owl says the notice "does not change the financial commitments" (TechCrunch). On 17 September the New Mexico Supreme Court unanimously lifted the stays that had frozen the air-permit hearing, although the state environment department still has to appoint a new hearing officer (KRWG). Oracle has also said the campus could fall back on grid power if the air permit fails (Organ Mountain News). Management said on 10 September that Jupiter does not affect this year's guidance.

Jupiter is part of Stargate, the programme launched at the White House in January 2025, so Washington has every reason to see its permits cleared. No federal backstop has been promised, and the valuation gives the political support no value.

The chairman is not selling. A day after the 10-Q disclosed his trading plan for up to 50M shares, worth about $7B at the reference price, Larry Ellison cancelled it. The filing says no stock was sold under the plan and that he "has no other plans to sell any of his Oracle stock" (Oracle 8-K).

Catalyst calendar

28 October is the key date for the shares. Oracle AI World runs from 25 to 28 October at the Venetian in Las Vegas (Oracle). TD Cowen expects a financial analyst meeting on 28 October with updated fiscal 2030 targets (Yahoo Finance). Oracle has not announced that date.

At last year's meeting, on 16 October 2025, Oracle set fiscal 2030 targets of $225B of revenue and $21 of EPS, about 13% above consensus (TIKR). Magouyrk said seven deals with four customers, all of them other than OpenAI and including Meta, had brought in $65B in 30 days. The stock still fell the most in almost nine months the next day, about 7% (Bloomberg). Targets alone did not satisfy the market then. This time it wants a funding plan.

Item Bull reading Bear reading
FY30 targets $225B / $21 held or raised EPS cut, even if revenue rises
Funding Free-cash-flow path, equity cap Open-ended equity, no path
Customers Non-OpenAI backlog disclosed OpenAI share of backlog rises
AI infra margin 30–40% reaffirmed Range lowered
Delivery Gigawatt guide for FY27–28 Jupiter slips further

The base case expects the targets to be held and a partial funding path to be set out. Credit, not the first day's share move, is the better test. On Bloomberg's measure, confirmation would be five-year CDS moving from about 241bp back toward the ~160bp of June.

Timeline of Oracle catalysts from October 2026 to the September 2028 horizon, separating announced dates from estimated windows

Announced dates and estimated windows between now and the 30 September 2028 horizon. Hollow markers are unconfirmed.

Meta is the customer that matters most for reducing Oracle's dependence on OpenAI. Meta's Muse agent launched on 8 September, reached No. 1 on the US App Store on 18 September and has held the spot since (TechCrunch). Meta says Muse isolates each user's work in a dedicated virtual machine (Implicator). An agent that runs a machine per user creates demand for general-purpose compute, which Oracle sells alongside GPUs. Reuters has seen an internal memo in which Meta plans to double its computing capacity to 14GW in 2027 (Reuters via Investing.com). Oracle confirmed a Meta cloud deal in October 2025, with reports putting its value at about $20B (CNBC). A disclosed Meta expansion would do more than anything else to reduce reliance on OpenAI, and none has been reported yet.

Dates and what each will show:

Fundamental invalidation

The mechanism holds only while contracted backlog turns into earnings faster than depreciation, interest and dilution drain them. Research points to five observable developments that would break it:

When to add

These business developments would confirm the mechanism:

On valuation, extra exposure stays attractive on the model while the stock trades below about 12x base-case fiscal 2029 EPS, roughly $170. At that price more than 40% would remain to the $240.83 base-case target. A rally that comes without these confirmations would not meet the test.

Valuation and model

Fiscal 2029 runs from June 2028 to May 2029, and it is the year consensus free cash flow reaches zero. At the September 2028 horizon, the market will be pricing that year. The model therefore sets the price in two years as fiscal 2029 non-GAAP EPS multiplied by a P/E multiple. The consensus inputs are Bloomberg BEST figures dated 25 September 2026.

Scenario FY29 revenue Net margin Shares EPS P/E Price
Bear $120B 20% 3.30B $7.27 10x $72.73
Base $170B 26% 3.12B $14.17 17x $240.83
Bull $183B 27% 3.10B $15.94 22x $350.65

For reference, fiscal 2026 revenue was $67.4B and non-GAAP EPS $7.63. Fiscal 2027 guidance is at least $90B and $8.10.

How each input is set:

Dilution and credit. Today's 3.02B share count already includes the 141M shares sold last quarter. The mandatory convertible preferred adds about 25–31M shares in January 2029, after the horizon. S&P has rated Oracle BBB- since the July downgrade. At quarter end, Oracle's $125B of senior notes had a fair value of $105.7B, about 85% of face (Q1 FY27 10-Q). The equity case needs credit to stabilise, not to recover fully, and each scenario's multiple follows that path.

The model gives no value to the tax shield, so any benefit is extra upside. The One Big Beautiful Bill Act permanently restored 100% bonus depreciation for equipment acquired after 19 January 2025 (BDO). In the one-gigawatt example, that lifts the return from about 16% to between 18% and 19.5%, depending on when the deduction is taken. Oracle's filings do not show it yet. Last quarter's deferred-tax line was only −$73M, income taxes payable rose $546M, and the effective tax rate was 15.1% (Q1 FY27 10-Q).

Sensitivity. The probability-weighted target across bear weights and base-case multiples, with the other two weights scaled in proportion and returns from the 139.16 reference:

Bear weight Base at 13x Base at 15x Base at 17x
25% $206 (+48%) $219 (+57%) $232 (+67%)
35% $188 (+35%) $199 (+43%) $211 (+51%)
45% $171 (+23%) $180 (+29%) $189 (+36%)

Even at a 45% bear weight and a 13x base multiple, the weighted target is above the reference price.

ORCL scenario targets at 30 September 2028

Scenario prices at the 2028-09-30 horizon, in US dollars per share, calculated as fiscal 2029 non-GAAP EPS times the scenario P/E. The probabilities are our estimates. The probability-weighted target of $231.75 is the average of the three bars, weighted by probability. Valuation assumptions and calculations.

Scenarios

Each scenario is marked at 30 September 2028, and returns are measured from the 139.16 USD reference quote on price alone. The token's reinvested dividend is currently about 1.4% a year before withholding and comes on top of those returns.

The valuation section sets out each case's inputs; the weights rest on this reasoning. The bear case gets 25% because OpenAI's gap between revenue and compute bill is offset by its closed $122B round and a supplier base that spreads its risk. The base case gets the most weight, 45%, because existing contracts and guidance already cover what it needs. The bull case gets 30% because it also needs the credit market to change its view.

The probabilities are our estimates, with 2028-09-30 as the horizon.

Scenario Probability % Catalyst outcome Valuation driver Target price Trade price return %
Bear: OpenAI resets, half its ramp never arrives 25.00 OpenAI renegotiates; half its ramp never arrives; equity issued near the lows; credit at record wides FY29 revenue $120B, 20% margin, 3.30B shares: EPS $7.27 at a distressed 10x 72.73 (47.74)
Base: backlog converts on schedule 45.00 RPO converts on schedule; capex inside the $70B net ceiling; credit stabilises FY29 revenue $170B, 26% margin, 3.12B shares: EPS $14.17 at today's 17x 240.83 73.06
Bull: Street FY29 numbers, credit re-rates 30.00 Renewal premiums persist; free cash flow turns on schedule; CDS retraces FY29 revenue $183B, 27% margin, 3.10B shares: EPS $15.94 at 22x, still below Microsoft 350.65 151.98

Probability-weighted target: $231.75. Probability-weighted price return: +66.54%.

Appendix: the ORCLon token

Buying ORCLon spot on Felix gives unlevered exposure with no funding payments. Ondo issues ORCLon one-for-one against Oracle shares held at a US broker-dealer. The token tracks total return: rather than paying out Oracle's dividend, it reinvests it into the token, net of withholding tax (Ondo).

The token is a claim on Ondo Global Markets, a British Virgin Islands issuer. It is not a registered share and carries no voting rights or SIPC cover. Shares held at the US broker-dealer Alpaca back the token 1:1 in a bankruptcy-remote structure checked by independent attestations (MetaMask on Ondo Stocks). Minting and redemption run 24 hours a day, five days a week, and outside US market hours the token can drift from the stock price. The reference quote of 139.16 USD was taken on Saturday 26 September, about 1.5% above Oracle's $137.10 close on Friday 25 September. Felix charges a trading fee on each side.

Sources

Corbanu · Trade note · 27 September 2026

This article describes a proposed trade, not a confirmed execution. Corbanu is a publication, not individualized investment advice. Venue links may carry referral compensation. Publication policies.